Achieving Robust Drug Product Safety & Efficacy for Reduced Ocular Inflammation
Time: 9:15 am
day: Conference Day One
Details:
- Leveraging lessons from case studies to understand PLGA rods, peptides, degradable depos, polymer-based and matrix binding formulations for ophthalmic drug implants
- Running effective toxicology studies – examples of getting past the time frame
- Establishing effective re-dosage to avoid rapid release and reduce inflammatory response
- Setting up for success – how is manufacturing likely to change from research to development – commercial manufacturing / development process
